Adl Amini, Dominik
Okano, Ichiro
Oezel, Lisa
Zhu, Jiaqi
Chiapparelli, Erika
Shue, Jennifer
Sama, Andrew A.
Cammisa, Frank P.
Girardi, Federico P.
Hughes, Alexander P. http://orcid.org/0000-0001-7293-9672
Article History
Received: 5 March 2021
Revised: 3 June 2021
Accepted: 24 June 2021
First Online: 2 July 2021
Declarations
:
: DAA, IO, LO, JZ, EC, JS have no relevant financial or non-financial interests to disclose. AAS declares financial interests: Royalties: Ortho Development Corp; Private investments: Vestia Ventures MiRUS Investment LLC, ISPH II LLC, ISPH 3 LLC, VBros Venture Partners X Centinel Spine; Consulting: Clariance Inc, Kuros Bioscience AG, Medical Device Business Services Inc.; Speaking and Teaching Arrangements: DePuy Synthes Products Inc.; Trips/Travel: Medical Device Business Services Inc; Research Support: Spinal Kinetcs Inc. FPC declares financial interests: Royalties: NuVasive Inc; Private investments: Bonovo Orthopedics Inc, Healthpoint Capital Partners LP, ISPH II LLC, Ivy Healthcare Capital Partners LLC, Medical Device Partners II LLC, Medical Device Partners III LLC, Orthobond Corporation, Spine Biopharma LLC, Tissue Differentiation Intelligence LLC, VBVP VI LLC, Woven Orthopedics Technologies; Consulting: 4Web Medical/4Web Inc, Spine Biopharma LLC, Research Support: 4Web Medical/4Web Inc, Beatrice & Samuel A. Seaver Foundation; Non-financial interests: Scientific Advisory Board: Healthpoint Capital Partners LP, Orthobond Corporation, Spine Biopharma LLC, Woven Orthopedic Technologies. FPG declares financial interests: Royalties: NuVasive Inc, Ortho Development Corp, Zimmer Biomet Holdings INC; Stock Ownership: Bonovo Orthopedics Inc, Liventa Bioscience (AF Cell Medical), Paradigm Spine LLC, Healthpoint Capital Partners LP, Alphatec Holdings LLC, LANX Inc, Centinel Spine Inc (fka Raymedica LLC), Tissue Differentiation Intelligence LLC, Spine Kinetics Inc; Consulting: DePuy Synthes Spine, NuVasive Inc, Non-financial interests: Consulting: EIT Emerging Implant Technologies, Spineart USA Inc, Ethicon Inc,. APH declares financial interests: Research Support: 4Web Medical; Fellowship Support: NuVasive Inc, Kuros Bioscience B.V. (Fig.InternalRef removed)
: This study was approved by our hospital’s Institutional Review Board, and informed consent was waived due to the retrospective nature of this study. (IRB# 2014–097).Figure removed